Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

Session 94   Poster Abstracts
Resistance Predictors of Virologic Response and Clinical Outcome
Tuesday, 1:30 - 3:30 pm
Poster Hall
669A Genotypic Score for Efavirenz Hypersusceptibility Is Associated with Virologic Response to EFV + Indinavir +/- Abacavir in Nucleoside-experienced Patients
L Demeter*1, V DeGruttola2, S Lustgarten2, S Eshleman3, S Hammer4, M Fischl5, and K Squires6
1Univ. of Rochester, NY, USA; 2Harvard Sch. of Publ. Hlth., Boston, MA, USA; 3Johns Hopkins Univ., Baltimore, MD, USA; 4Columbia Univ., New York, NY, USA; 5Univ. of Miami, FL, USA; and 6Keck Sch. of Med., Univ. of Southern California, Los Angeles, USA
670Comparison of Genotype and Phenotype as Predictors of Short-term Virologic Response to Didanosine in Nucleoside Analogue-experienced Patients
F Clavel*1, AG Marcelin2, J Pavie3, N Schmidely4, I Dujardin4, G Leleu4, V Calvez2, and J M Molina3
1Inserm U552, Paris, France; 2Hosp. Pitié-Salpétrière, Paris, France; 3Hosp. Saint Louis, Paris, France; and 4Bristol-Myers Squibb, Rueil, France
671Delavirdine Hypersusceptibility: Virologic Response and Phenotypic Cut-points--Results from ACTG 359
R Haubrich*1, H Jiang2, R Swanstrom3, M Bates4, D Katzenstein5, S Fiscus3, and R Gulick6
1Univ. of California, San Diego, USA; 2Harvard Sch. of Publ. Hlth., Boston, MA, USA; 3Univ. of North Carolina at Chapel Hill, USA; 4ViroLogic Inc., South San Francisco, CA, USA; 5Stanford Univ. Med. Ctr., Palo Alto, CA, USA; and 6Weill Med. Coll. of Cornell Univ., New York, NY, USA
672
Baseline Genotype as a Predictor of Virological Failure in Patients Receiving Emtricitabine Once Daily or Stavudine Twice Daily in Combination with Didanosine and Efavirenz
K Borroto-Esoda*, J Harris, J Waters, J Hinkle, A Shaw, J Quinn, and F Rousseau
Gilead Sci., Inc., Durham, NC, USA
673Genotype Interpretation Algorithm for Predicting Virological Response in HIV-1-infected Patients Receiving Ritonavir-boosted Indinavir
C Chappey*, C J Petropoulos, and N T Parkin
ViroLogic Inc., South San Francisco, CA, USA
674Reduced Sensitivity to Antiretrovirals Is Associated with an Increased Risk of Death among Persons Initiating HAART
RS Hogg*, C S Alexander, B Yip, T Mo, J Woodward, W Dong, B Wynhoven, L Ting, M V O’Shaughnessy, J S G Montaner, P R Harrigan, and HOMER Cohort
British Columbia Ctr. for Excellence in HIV/AIDS, Vancouver, Canada
675Genotypic vs Real Phenotypic Tests to Guide Salvage Antiretroviral Therapy in Heavily Pretreated Patients with Virological Failure: A 48 Weeks Prospective, Randomized Study (VIHRES Study)
J Blanco*1, A Guelar2, P Domingo3, E De Lazari1, G Valdecillo2, J R Arroyo3, A Biglia1, M Arnedo1, H Knobel2, T Pumarola1, J M Gatell1, and J Mallolas*1
1Hosp. Clin., Barcelona, Spain; 2Hosp. del Mar, Barcelona, Spain; and 3Hosp. Santa Creu i San Pau, Barcelona, Spain